Laman UtamaIPCALAB • NSE
add
IPCA Laboratories Ltd
Tutup sebelumnya
₹1,579.65
Julat hari
₹1,574.55 - ₹1,600.35
Julat tahun
₹1,052.00 - ₹1,755.90
Permodalan pasaran
401.92B INR
Bilangan Purata
597.02K
Nisbah P/E
60.77
Hasil dividen
0.25%
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(INR) | Sep 2024info | Perubahan T/T |
---|---|---|
Hasil | 23.55B | 15.78% |
Perbelanjaan pengendalian | 12.55B | 11.53% |
Pendapatan bersih | 2.29B | 58.20% |
Margin untung bersih | 9.74 | 36.61% |
Pendapatan bagi setiap syer | 9.05 | 58.22% |
EBITDA | 4.41B | 41.84% |
Kadar cukai berkesan | 28.80% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(INR) | Sep 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 9.03B | -3.30% |
Jumlah aset | 114.24B | 0.35% |
Jumlah liabiliti | 33.06B | -13.52% |
Jumlah ekuiti | 81.18B | — |
Syer tertunggak | 253.57J | — |
Harga kepada buku | 5.98 | — |
Pulangan pada aset | — | — |
Pulangan pada modal | 9.23% | — |
Aliran Tunai
Perubahan bersih dalam tunai
(INR) | Sep 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | 2.29B | 58.20% |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients. Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules. Wikipedia
Diasaskan
19 Okt 1949
Tapak web
Pekerja
17,335